Immunology

  1. Heterogeneity of neutrophils and inflammatory responses in patients with COVID-19 and healthy controls

    1. Jintao Xu
    2. Bing He
    3. Kyle Carver
    4. Debora Vanheyningen
    5. Brian Parkin
    6. Lana X. Garmire
    7. Michal A. Olszewski
    8. Jane C. Deng

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike

    1. Mathieu Claireaux
    2. Tom G. Caniels
    3. Marlon de Gast
    4. Julianna Han
    5. Denise Guerra
    6. Gius Kerster
    7. Barbera D. C. van Schaik
    8. Aldo Jongejan
    9. Angela I. Schriek
    10. Marloes Grobben
    11. Philip J. M. Brouwer
    12. Karlijn van der Straten
    13. Yoann Aldon
    14. Joan Capella-Pujol
    15. Jonne L. Snitselaar
    16. Wouter Olijhoek
    17. Aafke Aartse
    18. Mitch Brinkkemper
    19. Ilja Bontjer
    20. Judith A. Burger
    21. Meliawati Poniman
    22. Tom P. L. Bijl
    23. Jonathan L. Torres
    24. Jeffrey Copps
    25. Isabel Cuella Martin
    26. Steven W. de Taeye
    27. Godelieve J. de Bree
    28. Andrew B. Ward
    29. Kwinten Sliepen
    30. Antoine H. C. van Kampen
    31. Perry D. Moerland
    32. Rogier W. Sanders
    33. Marit J. van Gils

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Systems immune profiling of variant-specific vaccination against SARS-CoV-2

    1. Lei Peng
    2. Jonathan J. Park
    3. Zhenhao Fang
    4. Xiaoyu Zhou
    5. Matthew B. Dong
    6. Qiancheng Xiong
    7. Chenxiang Lin
    8. Sidi Chen

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Macaque-human differences in SARS-CoV-2 Spike antibody response elicited by vaccination or infection

    1. Alexandra C. Willcox
    2. Kevin Sung
    3. Meghan E. Garrett
    4. Jared G. Galloway
    5. Megan A. O’Connor
    6. Jesse H. Erasmus
    7. Jennifer K. Logue
    8. David W. Hawman
    9. Helen Y. Chu
    10. Kim J. Hasenkrug
    11. Deborah H. Fuller
    12. Frederick A. Matsen
    13. Julie Overbaugh

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Broad human and animal coronavirus neutralisation by SARS-CoV-2 S2-targeted vaccination

    1. Kevin W. Ng
    2. Nikhil Faulkner
    3. Katja Finsterbusch
    4. Mary Wu
    5. Ruth Harvey
    6. Saira Hussain
    7. Maria Greco
    8. Yafei Liu
    9. Svend Kjaer
    10. Charles Swanton
    11. Sonia Gandhi
    12. Rupert Beale
    13. Steve J. Gamblin
    14. Peter Cherepanov
    15. John McCauley
    16. Rodney Daniels
    17. Michael Howell
    18. Hisashi Arase
    19. Andeas Wack
    20. David L.V. Bauer
    21. George Kassiotis

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Heteologous saRNA-Prime, DNA Dual-Antigen-Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies

    1. Adrian Rice
    2. Mohit Verma
    3. Emily Voigt
    4. Peter Battisti
    5. Sam Beaver
    6. Sierra Reed
    7. Kyle Dinkins
    8. Shivani Mody
    9. Lise Zakin
    10. Shiho Tanaka
    11. Brett Morimoto
    12. C. Anders Olson
    13. Elizabeth Gabitzsch
    14. Jeffrey T. Safrit
    15. Patricia Spilman
    16. Corey Casper
    17. Patrick Soon-Shiong

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. SARS-CoV-2–specific T cells in unexposed adults display broad trafficking potential and cross-react with commensal antigens

    1. Laurent Bartolo
    2. Sumbul Afroz
    3. Yi-Gen Pan
    4. Ruozhang Xu
    5. Lea Williams
    6. Chin-Fang Lin
    7. Ceylan Tanes
    8. Kyle Bittinger
    9. Elliot S. Friedman
    10. Phyllis A. Gimotty
    11. Gary D. Wu
    12. Laura F. Su

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis

    1. Saptarshi Sinha
    2. Vanessa Castillo
    3. Celia R. Espinoza
    4. Courtney Tindle
    5. Ayden G. Fonseca
    6. Jennifer M. Dan
    7. Gajanan D. Katkar
    8. Soumita Das
    9. Debashis Sahoo
    10. Pradipta Ghosh

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD

    1. Xiaofei Wang
    2. Ao Hu
    3. Xiangyu Chen
    4. Yixin Zhang
    5. Fei Yu
    6. Shuai Yue
    7. Arong Li
    8. Junsong Zhang
    9. Zhiwei Pan
    10. Yang Yang
    11. Yao Lin
    12. Leiqiong Gao
    13. Jing Zhou
    14. Jing Zhao
    15. Fang Li
    16. Yaling Shi
    17. Feng Huang
    18. Xiaofan Yang
    19. Yi Peng
    20. Luoyang Tu
    21. Huan Zhang
    22. Huanying Zheng
    23. Jun He
    24. Hui Zhang
    25. Lifan Xu
    26. Qizhao Huang
    27. Yongqun Zhu
    28. Kai Deng
    29. Lilin Ye

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. A recombinant SARS-CoV-2 RBD antigen expressed in insect cells elicits immunogenicity and confirms safety in animal models

    1. Ricardo Choque-Guevara
    2. Astrid Poma-Acevedo
    3. Ricardo Montesinos-Millán
    4. Dora Rios-Matos
    5. Kristel Gutiérrez-Manchay
    6. Angela Montalvan
    7. Stefany Quiñones-Garcia
    8. Maria de Grecia Cauti-Mendoza
    9. Andres Agurto-Arteaga
    10. Ingrid Ramirez-Ortiz
    11. Manuel Criollo-Orozco
    12. Edison Huaccachi-Gonzales
    13. Yomara K. Romero Lázaro
    14. Norma Perez-Martinez
    15. Gisela Isasi-Rivas
    16. Yacory Sernaque-Aguilar
    17. Doris Villanueva-Pérez
    18. Katherine Vallejos-Sánchez
    19. Manolo Fernández-Sánchez
    20. Luis Guevara
    21. Manolo Fernández-Díaz
    22. Mirko Zimic
    23. for the COVID-19 Working Group in Perú

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 87 of 174 Next